Why We Invested in Cymulate: Managing Cyber Risk Posture, End-to-End 

To put it simply: we love seeing our portfolio companies succeed. We invest because we want to enable visionary entrepreneurs to become founders of great companies that solve enterprise problems. 

Today, Cymulate announced a $70M Series D round, making the investment among the largest for continuous security testing vendors. It’s been incredible working with this market leader in Extended Security Posture Management (XSPM) over the years. They’ve come so far in such a short amount of time that we feel compelled to reflect on our journey together. 

We were first introduced to Cymulate in 2019 by Alon Weinberg. Instantly, our team was impressed with the business acumen, successful track record and technology vision of the founders, Eyal Wachsman and Avihai Ben-Yossef. And the technology worked. It was clear that Cymulate’s security testing platform was in a category of its own, thanks to its ability to address a variety of business challenges. The founding team understood that periodic penetration testing was no match for today’s threat landscape. Instead, testing needed to be continuous and available on-demand, for different purposes.

Cymulate’s SaaS-based, end-to-end platform quickly set the industry standard for how organizations should continuously validate the effectiveness of their cyber security posture through automation. The threat landscape includes more of the same (ransomware, APTs, malware, the list goes on) but organizations struggle with effective combat. The persistence of these attacks is no match for a company without proper resources, as well as well-resourced companies with neither visibility nor clarity. Cymulate’s XSPM platform leverages native offensive security technology and capabilities to widely support a customer’s security and business needs – all through the power of translating findings to contextual, data-driven insights for better decision making.

Over the years, the company continuously proves its worth. Industry analysts like Gartner and a healthy cadence of funding validates that Cymulate is destined for greatness. In the last year alone, the company increased its ARR by more than 2x, growing more than 200% in North America alone, and counts hundreds of companies (many of which are Fortune 500) as satisfied customers. 

On behalf of everyone at Dell Technologies Capital, we’re honored to stand alongside Cymulate as the company continues to hit milestone after milestone. 

Team DTC